Naveed Shams
Chairman chez InnFocus, Inc.
Profil
Actuellement, Naveed K. Shams occupe le poste de Chief Scientific Officer, General Manager-R&D chez Santen Pharmaceutical Co., Ltd, Chairman chez InnFocus, Inc. (une filiale de Santen Pharmaceutical Co., Ltd.) et de directeur scientifique de ProQR Therapeutics NV. Au cours de sa carrière, il a occupé les postes de CMO, de vice-président principal de la recherche et du développement chez OPKO Health, Inc, de scientifique principal et de chef du groupe Glaucome-Discovery chez Storz Ophthalmics, Inc, de président, de directeur général et de directeur chez Santen, Inc, de directeur médical principal chez Genentech, Inc, de directeur des sciences cliniques chez Novartis Ophthalmics, Inc et de membre de la faculté de recherche du Schepens Eye Research Institute. Naveed K. Shams a obtenu un diplôme d'études supérieures du Dow Medical College et un doctorat de l'université de Caroline du Sud.
Postes actifs de Naveed Shams
| Sociétés | Poste | Début |
|---|---|---|
InnFocus, Inc.
 InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Chairman | - |
Anciens postes connus de Naveed Shams
| Sociétés | Poste | Fin |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Chief Tech/Sci/R&D Officer | 01/01/2022 |
| OPKO HEALTH, INC. | Chief Tech/Sci/R&D Officer | 10/06/2009 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/11/2007 |
Novartis Ophthalmics, Inc.
 Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Chief Tech/Sci/R&D Officer | 01/09/2003 |
| Storz Ophthalmics, Inc. | Corporate Officer/Principal | 01/03/1998 |
Formation de Naveed Shams
| University of South Carolina | Doctorate Degree |
| Dow Medical College | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
| OPKO HEALTH, INC. | Health Services |
| PROQR THERAPEUTICS N.V. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The Schepens Eye Research Institute, Inc.
 The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Schepens Eye Research Institute, Inc. operates as an eye research institute. It offers treatment for macular degeneration, diabetic retinopathy, glaucoma, other types of retinal and optic nerve degenerations and damage, dry eye and eye tissue transplants. The company was founded by Charles L. Schepens in 1950 and is headquartered in Boston, MA. | Commercial Services |
Santen, Inc.
 Santen, Inc. Medical SpecialtiesHealth Technology Part of Santen Pharmaceutical Co., Ltd., Santen, Inc. is a private company that develops ophthalmic products. The company is based in Emeryville, CA. The company was founded in 1993 by Adrienne L. Graves. Tatsuya Kaihara has been the CEO of the company since 2017. | Health Technology |
| Storz Ophthalmics, Inc. | |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Ophthalmics, Inc. was a producer of pharmaceuticals, eye care and generic drugs. The company was headquartered in Duluth, GA. | Health Technology |
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology InnFocus, Inc. operates as an ophthalmology company that provides products for glaucoma surgery. Its product, InnFocus MicroShunt, is a glaucoma drainage implant consisting of a micro-tube twice the size of an eyelash. The company was founded by Leonard Pinchuk and John B. Martin Jr. in 2004 and is headquartered in Miami, FL. | Health Technology |
